Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve Audited Financial Results For The ....

Negative operating cash flowResults View source PDF Explain this filing

ANUHPHR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.6%Reaction day

₹78.26

prior close

₹79.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.4%+0.8% vs market

Pharmaceuticals peers, median of 159sector-0.7%+0.1% vs sector

On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 0.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.3

10m

-1.3

15m

-1.9

30m

-1.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.6-1.4+0.8-0.7+0.1

Next day

+2.2-0.9+3.1+0.0+2.2

+4.1-0.3+4.5+0.2+3.9

-2.2+0.8-3.0+1.2-3.4

-2.3+0.9-3.2+0.4-2.7

-2.4+2.5-4.8+1.1-3.5

-2.2+3.1-5.4+1.8-4.0

15d

-0.8+3.5-4.3+1.4-2.2

+2.0+8.0-6.0+2.8-0.9

+3.5+9.3-5.8+8.2-4.8

-2.9+14.0-16.9+8.7-11.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anuh Pharma Ltd has informed BSE and NSE that a Board meeting is scheduled for May 20, 2026 to consider and approve the Audited Financial Results for Q4 and FY 2025-26 (year ended March 31, 2026). The meeting will also consider recommending a dividend for FY 2025-26, approve the Draft Statutory and Secretarial Audit Reports, and review the Director's Report. Additionally, the Board will decide on re-appointments of two directors retiring by rotation (Mr. Bipin Nemchand Shah and Mr. Arun Lalchand Todarwal). The meeting will also fix the date for the AGM and Book Closure Date. No specific financial figures or qualitative opinions are mentioned in this intimation.

Likely market impact

This is a routine pre-result announcement notice. Shareholders should note that the trading window remains closed until 48 hours after results declaration (till May 22, 2026). The actual impact on the stock will depend on the financial results and any accompanying disclosures that will be released after the Board meeting.

By the numbersStandalone · Q4 FY26 vs Q4 FY25

	Q4 FY26	Q4 FY25	Change
Revenue	₹202.1 Cr	₹198.1 Cr	+2.0%
Operating profit	₹16.77 Cr	₹15.88 Cr	+5.6%
Profit after tax	₹11.68 Cr	₹12.46 Cr	−6.2%
EBITDA margin	9.8%	9.4%	+0.4 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.